Piriou V, Ross S, Bastien O, Pigott D, Trivin F, Foëx P
Nuffield Department of Anaesthetics, Radcliffe Infirmary, University of Oxford.
Br J Anaesth. 1998 Apr;80(4):481-7. doi: 10.1093/bja/80.4.481.
Nicorandil, a new KATP channel opener, is used in clinical practice for anti-anginal therapy. It exhibits vasodilator properties as does the halogenated anaesthetic isoflurane. We have examined the cardiovascular effects of increasing concentrations of isoflurane after administration of nicorandil in 10 adult beagle dogs anaesthetized with thiopental and whose lungs were ventilated mechanically. During surgery, anaesthesia was maintained with 1.0-1.5% isoflurane. A left thoracotomy was performed and the heart suspended in a pericardial cradle. Monitoring included: ECG; aortic, left ventricular, arterial, central venous and pulmonary artery pressures; cardiac output; coronary flow; and segmental length in the apical region. After surgery, isoflurane anaesthesia was set at an end-tidal concentration of 1.05% (1 MAC) and measurements obtained; these were repeated with 1.4%, 1.75%, 2.1% and 1.05% isoflurane concentrations after appropriate stabilization periods. Nicorandil (100 micrograms kg-1 bolus, 25 micrograms kg-1 min-1 infusion) was begun and a second dose-response study of isoflurane was obtained as before. Blood samples were obtained for measurement of concentrations of nicorandil. Systolic ventricular function was assessed by systolic shortening (%SS) and preload recruitable stroke work (PRSW). Increasing isoflurane concentration produced decreases in heart rate, systolic pressure, cardiac output, %SS and PRSW. Nicorandil produced a slight decrease in systolic arterial pressure (10 and 15 mm Hg after 1.05% and 2.05% isoflurane) and a slight increase in heart rate (10 and 5 beat min-1 after 1.05% and 2.05% isoflurane). Preload, assessed by end-diastolic length, decreased. Coronary blood flow increased with infusion of nicorandil. Left ventricular function was not affected by infusion of nicorandil. We conclude that nicorandil has only minor vaso/venodilatory effects in the presence of isoflurane. Ventricular function was not altered by infusion of nicorandil.
尼可地尔是一种新型的钾通道开放剂,在临床实践中用于抗心绞痛治疗。它与卤化麻醉药异氟烷一样具有血管舒张特性。我们在10只硫喷妥钠麻醉、机械通气的成年比格犬中,研究了给予尼可地尔后增加异氟烷浓度时的心血管效应。手术过程中,用1.0 - 1.5%的异氟烷维持麻醉。进行左胸切开术,将心脏悬吊在心包支架中。监测项目包括:心电图;主动脉、左心室、动脉、中心静脉和肺动脉压力;心输出量;冠状动脉血流量;以及心尖区域的节段长度。手术后,将异氟烷麻醉设置为呼气末浓度1.05%(1个最低肺泡有效浓度)并进行测量;在适当的稳定期后,分别用1.4%、1.75%、2.1%和1.05%的异氟烷浓度重复测量。开始给予尼可地尔(100微克/千克静脉推注,25微克/千克·分钟静脉输注),并如前一样进行第二次异氟烷剂量反应研究。采集血样测量尼可地尔浓度。通过收缩期缩短率(%SS)和可预负荷增加的每搏功(PRSW)评估收缩期心室功能。增加异氟烷浓度会导致心率、收缩压、心输出量、%SS和PRSW降低。尼可地尔使收缩期动脉压略有下降(在1.05%和2.05%异氟烷时分别下降10和15毫米汞柱),心率略有增加(在1.05%和2.05%异氟烷时分别增加10和5次/分钟)。通过舒张末期长度评估的前负荷降低。输注尼可地尔使冠状动脉血流量增加。输注尼可地尔对左心室功能无影响。我们得出结论,在存在异氟烷的情况下,尼可地尔仅具有轻微的血管/静脉舒张作用。输注尼可地尔未改变心室功能。